Inositol synthesis regulates the activation of GSK-3α in neuronal cells

Journal of Neurochemistry

Volumn 133, Issue 2, 2015, Pages 273-283

  Ye, Cunqi ^a   Greenberg, Miriam L ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

bipolar disorder; glycogen synthesis kinase; Inositol; inositol depletion; myo inositol 3 phosphate synthase; valproic acid

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3ALPHA; INOSITOL; LITHIUM CHLORIDE; VALPROIC ACID; COTRANSPORTER; D-MYO-INOSITOL-3-PHOSPHATE SYNTHASE; ENZYME INHIBITOR; GLUCOSE TRANSPORTER; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 ALPHA; HEAT SHOCK PROTEIN; ISOMERASE; MESSENGER RNA; SLC2A13 PROTEIN, HUMAN; SLC5A3 PROTEIN, HUMAN;

ARTICLE; CARBOHYDRATE SYNTHESIS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; GENE; GENE SILENCING; INO1 GENE; NERVE CELL; PRIORITY JOURNAL; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTRACELLULAR FLUID; METABOLISM; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GLYCOGEN SYNTHASE KINASE 3; HEAT-SHOCK PROTEINS; HUMANS; INOSITOL; INTRACELLULAR FLUID; INTRAMOLECULAR LYASES; NEUROBLASTOMA; RNA, MESSENGER; SYMPORTERS; VALPROIC ACID;

EID: 84926661652     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12978     Document Type: Article

References (92)

1. Acevedo L. D., Holloway H. W., Rapoport S. I., and, Shetty H. U., (1997) Application of stable isotope tracer combined with mass spectrometric detection for studying myo-inositol uptake by cultured neurons from fetal mouse: effect of trisomy 16. J. Mass Spectrom. 32, 395-400.
2. Allison J. H., and, Stewart M. A., (1971) Reduced brain inositol in lithium-treated rats. Nat. New Biol. 233, 267-268.
3. Aukema H. M., and, Holub B. J., (1994) Inositol and Pyrroloquinoline Quinone. A: Inositol. pp. 466-473. Lea and Febiger, Philadelphia.
4. Azab A. N., He Q., Ju S., Li G., and, Greenberg M. L., (2007) Glycogen synthase kinase-3 is required for optimal de novo synthesis of inositol. Mol. Microbiol. 63, 1248-1258.
5. Bachhawat N., Ouyang Q., and, Henry S. A., (1995) Functional characterization of an inositol-sensitive upstream activation sequence in yeast. A cis-regulatory element responsible for inositol-choline mediated regulation of phospholipid biosynthesis. J. Biol. Chem. 270, 25087-25095.
6. Beaulieu J. M., Marion S., Rodriguiz R. M., Medvedev I. O., Sotnikova T. D., Ghisi V., Wetsel W. C., Lefkowitz R. J., Gainetdinov R. R., and, Caron M. G., (2008) A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 132, 125-136.
7. Belmaker R. H., Shapiro J., Vainer E., Nemanov L., Ebstein R. P., and, Agam G., (2002) Reduced inositol content in lymphocyte-derived cell lines from bipolar patients. Bipolar Disord. 4, 67-69.
8. Berridge M. J., Downes C. P., and, Hanley M. R., (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59, 411-419.
9. Berry G. T., Mallee J. J., Kwon H. M., Rim J. S., Mulla W. R., Muenke M., and, Spinner N. B., (1995) The human osmoregulatory Na+/myo-inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21. Genomics 25, 507-513.
10. Berry G. T., Buccafusca R., Greer J. J., and, Eccleston E., (2004) Phosphoinositide deficiency due to inositol depletion is not a mechanism of lithium action in brain. Mol. Genet. Metab. 82, 87-92.
11. Cantley L. C., (2002) The phosphoinositide 3-kinase pathway. Science 296, 1655-1657.
12. Carman G., and, Han G.-S., (2011) Regulation of phospholipid synthesis in the yeast Saccharomyces cerevisiae. Annu. Rev. Biochem. 80, 859-883.
13. Chen G., Huang L. D., Jiang Y. M., and, Manji H. K., (1999) The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J. Neurochem. 72, 1327-1330.
14. Chen P. S., Peng G. S., Li G., et al,. (2006) Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol. Psychiatry 11, 1116-1125.
15. Chen M., Hancock L. C., and, Lopes J. M., (2007) Transcriptional regulation of yeast phospholipid biosynthetic genes. Biochim. Biophys. Acta 1771, 310-321.
16. Cohen P., and, Frame S., (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2, 769-776.
17. Cory A. H., Owen T. C., Barltrop J. A., and, Cory J. G., (1991) Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 3, 207-212.
18. Cross D. A., Alessi D. R., Cohen P., Andjelkovich M., and, Hemmings B. A., (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
19. Culbertson M. R., and, Henry S. A., (1975) Inositol-requiring mutants of Saccharomyces cerevisiae. Genetics 80, 23-40.
20. Czech M. P., (2003) Dynamics of phosphoinositides in membrane retrieval and insertion. Annu. Rev. Physiol. 65, 791-815.
21. De Camilli P., Emr S. D., McPherson P. S., and, Novick P., (1996) Phosphoinositides as regulators in membrane traffic. Science 271, 1533-1539.
22. De Sarno P., Li X., and, Jope R. S., (2002) Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43, 1158-1164.
23. Deranieh R. M., He Q., Caruso J. A., and, Greenberg M. L., (2013) Phosphorylation regulates myo-inositol-3-phosphate synthase: a novel regulatory mechanism of inositol biosynthesis. J. Biol. Chem. 288, 26822-26833.
24. Di Daniel E., Mok M. H., Mead E., et al,. (2009) Evaluation of expression and function of the H+/myo-inositol transporter HMIT. BMC Cell Biol. 10, 54.
25. Di Paolo G., and, De Camilli P., (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443, 651-657.
26. Eagle H., (1955) The specific amino acid requirements of a human carcinoma cell (Stain HeLa) in tissue culture. J. Exp. Med. 102, 37-48.
27. Eagle H., Oyama V. I., Levy M., and, Freeman A. E., (1957) Myo-Inositol as an essential growth factor for normal and malignant human cells in tissue culture. J. Biol. Chem. 226, 191-205.
28. Eickholt B. J., Towers G. J., Ryves W. J., Eikel D., Adley K., Ylinen L. M., Chadborn N. H., Harwood A. J., Nau H., and, Williams R. S., (2005) Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure. Mol. Pharmacol. 67, 1426-1433.
29. Eisenberg F., Jr, (1967) D-myoinositol 1-phosphate as product of cyclization of glucose 6-phosphate and substrate for a specific phosphatase in rat testis. J. Biol. Chem. 242, 1375-1382.
30. Fu H., Li B., Hertz L., and, Peng L., (2012) Contributions in astrocytes of SMIT1/2 and HMIT to myo-inositol uptake at different concentrations and pH. Neurochem. Int. 61, 187-194.
31. Guan G., Dai P., and, Shechter I., (2003) cDNA cloning and gene expression analysis of human myo-inositol 1-phosphate synthase. Arch. Biochem. Biophys. 417, 251-259.
32. Hallcher L. M., and, Sherman W. R., (1980) The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem. 255, 10896-10901.
33. Henry S., Kohlwein S., and, Carman G., (2012) Metabolism and regulation of glycerolipids in the yeast Saccharomyces cerevisiae. Genetics 190, 317-349.
34. Henry S. A., Gaspar M. L., and, Jesch S. A., (2014) The response to inositol: regulation of glycerolipid metabolism and stress response signaling in yeast. Chem. Phys. Lipids, 180, 23-43.
35. Hirsch J. P., and, Henry S. A., (1986) Expression of the Saccharomyces cerevisiae inositol-1-phosphate synthase (INO1) gene is regulated by factors that affect phospholipid synthesis. Mol. Cell. Biol. 6, 3320-3328.
36. Hur E. M., and, Zhou F. Q., (2010) GSK3 signalling in neural development. Nat. Rev. Neurosci. 11, 539-551.
37. Jin N., Kovacs A. D., Sui Z., Dewhurst S., and, Maggirwar S. B., (2005) Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death. Neuropharmacology 48, 576-583.
38. Ju S., and, Greenberg M. L., (2003) Valproate disrupts regulation of inositol responsive genes and alters regulation of phospholipid biosynthesis. Mol. Microbiol. 49, 1595-1603.
39. Kao F. T., and, Puck T. T., (1968) Genetics of somatic mammalian cells, VII. Induction and isolation of nutritional mutants in Chinese hamster cells. Proc. Natl Acad. Sci. USA 60, 1275-1281.
40. Keith A. D., Pollard E. C., and, Snipes W., (1977) Inositol-less death in yeast results in a simultaneous increase in intracellular viscosity. Biophys. J. 17, 205-212.
41. Kim A. J., Shi Y., Austin R. C., and, Werstuck G. H., (2005) Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J. Cell Sci. 118, 89-99.
42. Kim J., Yang M., Kim S. H., Kim J. C., Wang H., Shin T., and, Moon C., (2013) Possible role of the glycogen synthase kinase-3 signaling pathway in trimethyltin-induced hippocampal neurodegeneration in mice. PLoS ONE 8, e70356.
43. Kindl H., and, Hoffmann-Ostenhof O., (1964) Studies on the biosynthesis of cyclitols. Ii. formation of meso-inositol from C14-1-glucose in sinapis alba and selective degradation of the resulting product. Biochem. Z. 339, 374-381.
44. Klein P. S., and, Melton D. A., (1996) A molecular mechanism for the effect of lithium on development. Proc. Natl Acad. Sci. USA 93, 8455-8459.
45. Lai K., and, McGraw P., (1994) Dual control of inositol transport in Saccharomyces cerevisiae by irreversible inactivation of permease and regulation of permease synthesis by INO2, INO4, and OPI1. J. Biol. Chem. 269, 2245-2251.
46. Lai K., Bolognese C. P., Swift S., and, McGraw P., (1995) Regulation of inositol transport in Saccharomyces cerevisiae involves inositol-induced changes in permease stability and endocytic degradation in the vacuole. J. Biol. Chem. 270, 2525-2534.
47. Lemmon M. A., (2003) Phosphoinositide recognition domains. Traffic 4, 201-213.
48. Loewen C. J., Gaspar M. L., Jesch S. A., Delon C., Ktistakis N. T., Henry S. A., and, Levine T. P., (2004) Phospholipid metabolism regulated by a transcription factor sensing phosphatidic acid. Science 304, 1644-1647.
49. Loewus F., and, Kelly S., (1962) Conversion of glucose to inositol in parsley leaves. Biochem. Biophys. Res. Commun. 7, 204-208.
50. Lucas F. R., and, Salinas P. C., (1997) WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. Dev. Biol. 192, 31-44.
51. Majerus P. W., and, York J. D., (2009) Phosphoinositide phosphatases and disease. J. Lipid Res. 50 (Suppl), S249-S254.
52. Maslanski J. A., and, Busa W. B., (1990) A sensitive and specific mass assay for myo-inositol and inositol phosphate, in Methods in Inositide Research (, Irvine R. F., ed), pp. 113-126. Raven Press, New York.
53. van Meer G., Voelker D., and, Feigenson G., (2008) Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112-124.
54. Michell R. H., (2008) Inositol derivatives: evolution and functions. Nat. Rev. Mol. Cell Biol. 9, 151-161.
55. Michell R. H., (2011) Inositol and its derivatives: their evolution and functions. Adv. Enzyme Regul. 51, 84-90.
56. Michell R. H., (2013) Inositol lipids: from an archaeal origin to phosphatidylinositol 3,5-bisphosphate faults in human disease. FEBS J. 280, 6281-6294.
57. Migaud M. E., and, Frost J. W., (1996) Elaboration of a general strategy for inhibition of myo-inositol 1-phosphate synthase: active site interactions of analogues possessing oxidized reaction centers. J. Am. Chem. Soc. 118, 495-501.
58. Miyakawa H., Woo S. K., Dahl S. C., Handler J. S., and, Kwon H. M., (1999) Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc. Natl Acad. Sci. USA 96, 2538-2542.
59. Novak J. E., Turner R. S., Agranoff B. W., and, Fisher S. K., (1999) Differentiated human NT2-N neurons possess a high intracellular content of myo-inositol. J. Neurochem. 72, 1431-1440.
60. Olgemoller B., Schwaabe S., Schleicher E. D., and, Gerbitz K. D., (1993) Upregulation of myo-inositol transport compensates for competitive inhibition by glucose. An explanation for the inositol paradox? Diabetes 42, 1119-1125.
61. Palmano K. P., Whiting P. H., and, Hawthorne J. N., (1977) Free and lipid myo-inositol in tissues from rats with acute and less severe streptozotocin-induced diabetes. Biochem. J. 167, 229-235.
62. Phiel C. J., Wilson C. A., Lee V. M., and, Klein P. S., (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423, 435-439.
63. Pollack S. J., Atack J. R., Knowles M. R., McAllister G., Ragan C. I., Baker R., Fletcher S. R., Iversen L. L., and, Broughton H. B., (1994) Mechanism of inositol monophosphatase, the putative target of lithium therapy. Proc. Natl Acad. Sci. USA 91, 5766-5770.
64. Rivera-Gonzalez R., Petersen D. N., Tkalcevic G., Thompson D. D., and, Brown T. A., (1998) Estrogen-induced genes in the uterus of ovariectomized rats and their regulation by droloxifene and tamoxifen. J. Steroid Biochem. Mol. Bio. 64, 13-24.
65. Rumpel H., Lim W. E., Chang H. M., Chan L. L., Ho G. L., Wong M. C., and, Tan K. P., (2003) Is myo-inositol a measure of glial swelling after stroke? A magnetic resonance study. J. Magn. Reson. Imaging 17, 11-19.
66. Ryves W. J., and, Harwood A. J., (2001) Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem. Biophys. Res. Commun. 280, 720-725.
67. Seelan R. S., Parthasarathy L. K., and, Parthasarathy R. N., (2004) E2F1 regulation of the human myo-inositol 1-phosphate synthase (ISYNA1) gene promoter. Arch. Biochem. Biophys. 431, 95-106.
68. Seelan R. S., Lakshmanan J., Casanova M. F., and, Parthasarathy R. N., (2009) Identification of myo-inositol-3-phosphate synthase isoforms: characterization, expression, and putative role of a 16-kDa gamma(c) isoform. J. Biol. Chem. 284, 9443-9457.
69. Seelan R. S., Pisano M. M., Greene R. M., Casanova M. F., and, Parthasarathy R. N., (2011) Differential methylation of the gene encoding myo-inositol 3-phosphate synthase (Isyna1) in rat tissues. Epigenomics. 3, 111-124.
70. Shaltiel G., Shamir A., Shapiro J., Ding D., Dalton E., Bialer M., Harwood A. J., Belmaker R. H., Greenberg M. L., and, Agam G., (2004) Valproate decreases inositol biosynthesis. Biol. Psychiatry 56, 868-874.
71. Shen X., Xiao H., Ranallo R., Wu W.-H., and, Wu C., (2003) Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates. Science (New York, N.Y.). 299: 112-114.
72. Sherman W. R., Packman P. M., Laird M. H., and, Boshans R. L., (1977) Measurement of myo-inositol in single cells and defined areas of the nervous system by selected ion monitoring. Anal. Biochem. 78, 119-131.
73. Shi Y., Vaden D. L., Ju S., Ding D., Geiger J. H., and, Greenberg M. L., (2005) Genetic perturbation of glycolysis results in inhibition of de novo inositol biosynthesis. J. Biol. Chem. 280, 41805-41810.
74. Shi Y., Azab A. N., Thompson M. N., and, Greenberg M. L., (2006) Inositol phosphates and phosphoinositides in health and disease. Subcell. Biochem. 39, 265-292.
75. Shimon H., Agam G., Belmaker R. H., Hyde T. M., and, Kleinman J. E., (1997) Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am. J. Psychiatry 154, 1148-1150.
76. Shimshoni J. A., Dalton E. C., Jenkins A., Eyal S., Ewan K., Williams R. S., Pessah N., Yagen B., Harwood A. J., and, Bialer M., (2007) The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior. Mol. Pharmacol. 71, 884-892.
77. Spector R., and, Lorenzo A. V., (1975) Myo-inositol transport in the central nervous system. Am. J. Physiol. 228, 1510-1518.
78. Spizz G., and, Pike L. J., (1992) Growth factors promote inositol uptake in BC3H1 cells. Biochem. Biophys. Res. Commun. 182, 1008-1015.
79. Srivastava A. K., and, Pandey S. K., (1998) Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin. Mol. Cell. Biochem. 182, 135-141.
80. Steger D., Haswell E., Miller A., Wente S., and, O'Shea E., (2003) Regulation of chromatin remodeling by inositol polyphosphates. Science (New York, N.Y.). 299, 114-116.
81. Stokes C. E., Gillon K. R., and, Hawthorne J. N., (1983) Free and total lipid myo-inositol concentrations decrease with age in human brain. Biochim. Biophys. Acta 753, 136-138.
82. Strausberg R. L., Feingold E. A., Grouse L. H., et al,. (2002) Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl Acad. Sci. USA 99, 16899-16903.
83. Uldry M., Steiner P., Zurich M. G., Beguin P., Hirling H., Dolci W., and, Thorens B., (2004) Regulated exocytosis of an H+/myo-inositol symporter at synapses and growth cones. EMBO J. 23, 531-540.
84. Vaden D. L., Ding D., Peterson B., and, Greenberg M. L., (2001) Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis. J. Biol. Chem. 276, 15466-15471.
85. Whitworth P., Heal D. J., and, Kendall D. A., (1990) The effects of acute and chronic lithium treatment on pilocarpine-stimulated phosphoinositide hydrolysis in mouse brain in vivo. Br. J. Pharmacol. 101, 39-44.
86. Williams R. S., Cheng L., Mudge A. W., and, Harwood A. J., (2002) A common mechanism of action for three mood-stabilizing drugs. Nature 417, 292-295.
87. Wolfson M., Hertz E., Belmaker R. H., and, Hertz L., (1998) Chronic treatment with lithium and pretreatment with excess inositol reduce inositol pool size in astrocytes by different mechanisms. Brain Res. 787, 34-40.
88. Wolfson M., Bersudsky Y., Zinger E., Simkin M., Belmaker R. H., and, Hertz L., (2000) Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations. Brain Res. 855, 158-161.
89. Wong Y. H., Kalmbach S. J., Hartman B. K., and, Sherman W. R., (1987) Immunohistochemical staining and enzyme activity measurements show myo-inositol-1-phosphate synthase to be localized in the vasculature of brain. J. Neurochem. 48, 1434-1442.
90. Ye C., Bandara W. M., and, Greenberg M. L., (2013) Regulation of inositol metabolism is fine-tuned by inositol pyrophosphates in Saccharomyces cerevisiae. J. Biol. Chem. 288, 24898-24908.
91. Yorek M. A., Dunlap J. A., and, Lowe W. L., Jr, (1998) Opposing effects of tumour necrosis factor alpha and hyperosmolarity on Na+/myo-inositol co-transporter mRNA levels and myo-inositol accumulation by 3T3-L1 adipocytes. Biochem. J. 336 (Pt 2), 317-325.
92. Zhang F., Phiel C. J., Spece L., Gurvich N., and, Klein P. S., (2003) Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. J. Biol. Chem. 278, 33067-33077.